Article
Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus.
Clinical and experimental rheumatology - 1 Jan 2000
Pullmann R, Lukác J, Skerenová M, Rovensky J, Hybenová J, Melus V, Celec S, Pullmann R, Hyrdel R
Abstract excerpt
OBJECTIVE: Genetic susceptibility to systemic lupus erythematosus (SLE) is conferred not only by various genes within the major histocompatibility complex (MHC) region, but also by several other non-MHC linked genes. The negatively signalling molecule CTLA-4 is involved in establishing and maintaining of peripheral T cell tolerance, which controls T cell activation and reactivity. Its attenuating action helps to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
